Maximizing Pharmaceutical Patent Life Cycles
The American Conference Institute (ACI) is hosting the Maximizing Pharmaceutical Patent Life Cycles conference. The program will address: the potential impact of pending Patent Reform Legislation on pharmaceutical patent life cycles, how the courts are interpreting the Hatch-Waxman reform provisions of the MMA, how Integra has impacted the Safe Harbor, authorized generics, and the impact of the Hatch-Waxman reform in the US on EU pharmaceutical patent practice.
Jane Gunnison and Denise Loring, both partners, will host a workshop called New Strategies for Obtaining Pharmaceutical Patent Extensions.